News

The Israeli health authorities have signed a supply agreement for the investigational Covid-19 plasma-derived Immunoglobulin (IgG), to be supplied by Kamada Ltd., a biopharmaceutical company which is partnered with Kedrion Biopharma in the development of the new anti-Covid-19 therapy. The...

The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would seek to enroll 28,500 volunteers aged 18 years and above. Covaxin, the coronavirus vaccine candidate...

Lonza announced a CHF85m (93m USD) investment in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health nutrition industry. The investment will enable the company to expand its overall production capacity...

Teknova, a leading manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has completed the United States FDA notification process for its CDC formulation Viral Transport Medium (VTM). Therefore, Teknova Viral Transport Medium is...

Recipharm is pleased to announce that the results of the study with Erdosteine as an add-on treatment for COVID-19 patients are now available. The clinical study involved 20 patients affected by COVID-19 with severe respiratory failure, hospitalized in one of...

Britain has signed supply deals for six different coronavirus vaccine candidates, including those being made by AstraZeneca and Pfizer and BioNTech, seen as among the frontrunners in the race for a vaccine. Britain on Thursday said it would partner with...

ATMPS's Hataali blockchain platform has been successfully tested with University Hospitals Birmingham NHS Foundation Trust’s system interface. Data interoperability was shown to be possible, rendering the Hataali platform as the world’s first blockchain solution for advanced therapeutic medicinal products (ATMP). Hataali...